Trial Comparing Elan Specialized Bariatric Supplements With Standard Multivitamins in Patients Undergoing Bariatric Procedures
NCT07021170 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 624
Last updated 2025-09-16
Summary
Obesity has escalated to pandemic levels, impacting over 650 million adults globally and significantly contributing to the burden of non-communicable diseases such as type 2 diabetes, cardiovascular disease, obstructive sleep apnea, non-alcoholic fatty liver disease, and infertility. The chronic, multifactorial nature of obesity presents substantial challenges for long-term management, as lifestyle modifications and pharmacotherapy often yield limited and transient success. In this context, Metabolic and bariatric surgery (MBS) has emerged as the most effective and enduring treatment for obesity, offering significant weight loss and marked improvement or remission of obesity-related comorbidities.
The most prevalent MBS procedures include sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), and one-anastomosis gastric bypass (OAGB). While these interventions offer considerable metabolic advantages, they inherently cause significant modifications to gastrointestinal anatomy and physiology, which can predispose patients to long-term micronutrient deficiencies. These deficiencies can stem from reduced dietary intake, altered gastric acid secretion, decreased intrinsic factor production, and the bypassing of critical absorptive sites in the gastrointestinal tract. Commonly affected nutrients encompass iron, vitamin B12, Vitamin B6, folate, vitamin D, calcium, and zinc. If not effectively managed, these nutrient deficiencies can lead to anemia, secondary hyperparathyroidism, osteopenia, neurological complications, immune dysfunction, and impaired postoperative recovery.
Population-based recommended dietary allowances (RDAs) and tolerable upper intake levels (ULs) tend to underestimate the nutritional requirements for postoperative patients, as they are derived from healthy cohorts. Many standard formulations may fall short due to inadequate dosages, non-bioavailable forms, or poor tolerability, which can significantly impact patient adherence to supplementation regimens. Over-the-counter multivitamins, such as Centrum®, are designed for the general population and often lack the dosing, bioavailability, or elemental forms required for post-MBS physiology, particularly following bypass procedures.
The American Society for Metabolic and Bariatric Surgery (ASMBS) recommends 8-22 mg of elemental zinc per day, depending on the procedure, and the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) and the World Gastroenterology Organization (WGO) recommend up to 30 mg/day for OAGB patients. These values are below the national upper limit in Egypt, which is 25 mg/day.
Moreover, there is evidence indicating a discrepancy in nutrient deficiencies among different bariatric surgery patients; for instance, OAGB patients exhibit a greater prevalence of iron and zinc deficiencies compared to those undergoing RYGB or SG, thereby necessitating proportionally higher supplementation tailored to their specific needs.
Conditions
- Vitamin Deficiencies
Interventions
- DIETARY_SUPPLEMENT
-
Elan Believe
Elan Believe is formulated specifically for patients undergoing SG and contains 18 mg of elemental zinc.
- DIETARY_SUPPLEMENT
-
Elan Compass
Elan Compass is tailored for RYGB and contains 24 mg of zinc.
- DIETARY_SUPPLEMENT
-
Elan Supreme
Designed for OAGB, provides 36 mg of zinc.
- DIETARY_SUPPLEMENT
-
Standard Multivitamins
Over-the-counter multivitamin containing 100% of the recommended daily allowance (RDA) for essential vitamins and minerals. Unlike the specialized formulations, the standard multivitamin is not designed to accommodate the altered gastrointestinal absorption characteristics of post-MBS patients.
Sponsors & Collaborators
-
General Committee of Teaching Hospitals and Institutes, Egypt
lead OTHER_GOV
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-06-15
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- Egypt
Study Locations
More Related Trials
-
Vitamin Supplementation After Bariatric Surgery
NCT02686905 ·Status: UNKNOWN ·Phase: NA
-
Effect of Protein Supplementation on Fat Free Mass Preservation After Bariatric Surgery
NCT05570474 ·Status: RECRUITING ·Phase: NA
-
Effects of a Novel Dietary Intervention on Body Composition After Laparoscopic Gastric Bypass Surgery
NCT01041261 ·Status: TERMINATED ·Phase: NA
-
Multivitamin Adherence Following Bariatric Surgery
NCT02124889 ·Status: COMPLETED ·Phase: NA
-
Fiber Supplementation After Bariatric Surgery
NCT05653648 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of a Modified Cost-Effective Dietary Plan in Promoting Weight Loss and Preservation of Lean Body Mass in Patients After Bariatric Surgery
NCT07111767 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Randomized Trial of Preoperative Diets Before Bariatric Surgery
NCT01652105 ·Status: UNKNOWN ·Phase: NA
-
Preventing Muscle Loss After Bariatric Surgery: Protein-Collagen Supplementation and Resistance Exercise
NCT07303543 ·Status: RECRUITING ·Phase: NA
-
Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)
NCT04605081 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Trial of Leptin Administration After Roux-en-Y Gastric Bypass
NCT00710814 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the Dietary Supplement Refill Bypass to Reduce Nutritional Deficiencies of Patients Who Underwent Bariatric Surgery
NCT02440087 ·Status: COMPLETED
-
Micro-nutritional Status and Gut Microbiota in Morbidly Obese Patients Before and After Gastric Bypass
NCT03029572 ·Status: COMPLETED ·Phase: NA
-
Vitamin Deficiencies and Suppletion in Morbid Obesity
NCT02270749 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Care Provided to Patients Who Underwent Bariatric Surgery and Were Lost to Follow-up 5 Years After Surgery
NCT07118540 ·Status: RECRUITING
-
Long-term Adverse Effects After Bariatric Surgery on Oesophagus Epithelium
NCT03410849 ·Status: COMPLETED ·Phase: NA
-
Controlled Trial Evaluating the Efficacy of Protein Supplementation in the Short Term After Bariatric Surgery
NCT02712086 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids in Bariatric Gastric Bypass Surgery: Effect on Liver Volume, Immune Response and Erythrocyte Function
NCT02206256 ·Status: COMPLETED ·Phase: PHASE4
-
Pancreatic Enzymes to Restore Digestive Function in Malnourished Gastric Bypass Patients
NCT00510744 ·Status: COMPLETED ·Phase: NA
-
Low-Volume Oral Carbohydrate Feeding in Bariatric Surgery: Effects on PONV and Recovery
NCT07018440 ·Status: COMPLETED ·Phase: NA
-
Outcome of Bariatric Surgery in Patients With BMI Greater Than 60 .
NCT04663425 ·Status: COMPLETED
-
Supplementation After Bariatric Surgery
NCT04412421 ·Status: UNKNOWN
-
Naltrexone/Bupropion With or Without Very Low Calorie Ketogenic Diet for Weight Regain After Bariatric Surgery
NCT06881485 ·Status: RECRUITING ·Phase: NA
-
Nutritional Deficiency After Bariatric Surgeries
NCT04717973 ·Status: COMPLETED
-
Analysis of the Influence of Gastric By-Pass on the Pharmacokinetics of Common Drugs
NCT06460896 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effects of an Information Video on Anxiety and Bariatric Surgery Knowledge Among Bariatric Surgery Candidates
NCT02857647 ·Status: COMPLETED ·Phase: NA